Coherence Neuro tests a brain-tumor-sensing implant in its first patients
At Royal Melbourne Hospital, the Cipher interface was placed for 30 minutes during tumor surgery in three people, a first step toward a glioblastoma therapy.
Coherence Neuro has begun its first human study. Surgeons led by Andrew Morokoff at Royal Melbourne Hospital placed its Cipher brain interface for about 30 minutes in three patients during brain tumor removal, to map and stimulate tissue. The company’s goal is a therapeutic BCI that senses the electrical signals of brain tumors and delivers stimulation to slow their growth. It plans a long-term implant study in glioblastoma starting in 2027.
Using neural interfaces against cancer, rather than for communication or movement, is a new direction for the field.
Learn more: ECoG · Closed-loop systems